As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.
On Monday, Ares Multi Strategy Credit Fund (ARMF)'s Director, David A. Sachs, made a $55,260 purchase of ARMF, buying 2,500 shares at a cost of $22.10 each. Investors can buy ARMF even cheaper than Sachs did, with shares trading as low as $21.75 at last check today -- that's 1.6% below Sachs's purchase price. Ares Multi Strategy Credit Fund is trading up about 0.2% on the day Wednesday. Before this latest buy, Sachs purchased ARMF at 2 other times during the past year, for a total cost of $390,700 at an average of $23.54 per share.
And at NeoGenomics (NASDAQ:NEO), there was insider buying on Friday, by Chief Medical Officer Maher Albitar who bought 14,492 shares for a cost of $3.51 each, for a total investment of $50,847. NeoGenomics is trading up about 4.5% on the day Wednesday. Albitar was up about 8.3% on the buy at the high point of today's trading session, with NEO trading as high as $3.80 in trading on Wednesday.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.